Loading...
XTSE
PRM
Market cap10mUSD
Jul 28, Last price  
11.40CAD
1D
-0.87%
1Q
-0.87%
IPO
-21.38%
Name

Big Pharma Split Corp

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
8.78%
Shrs. gr., 5y
-2.09%
Rev. gr., 5y
-37.36%
Revenues
312k
-91.60%
407,1113,232,0972,434,140589,2575,359,3683,710,644311,764
Net income
-140k
L
323,2212,780,0804,489,124265,4234,853,6373,145,517-139,680
CFO
12m
+950.88%
-30,954,2591,270,6748,679,1984,348,424-9,000,3591,128,42911,858,414
Dividend
Sep 27, 20240.1031 CAD/sh

Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
IPO date
Nov 23, 2017
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT